Skip to main content

In The News

Report highlights OTC analgesics’ role in managing acute pain

updated NSAID warnings

Pain Medicine News, with support from Johnson & Johnson Consumer Inc., has issued a Special Report on the role of OTC analgesics in acute pain management when considering opioid-sparing approaches, with contributions from healthcare professionals on the front lines. The Special Report, though not exhaustive, includes case studies, real-world clinical scenarios, a review of current guidelines, and efficacy and safety profiles of OTC pain relievers.

Click to show full story

FDA updates label requirements for OTC non-aspirin NSAIDs

updated NSAID warnings

The US Food and Drug Administration (FDA) recently required an update to the Drug Facts labeling of all adult, children’s, and infants’ non-aspirin over-the-counter (OTC) nonsteroidal anti-inflammatory drugs (NSAIDs), for example, Motrin®, Advil®, and Aleve® products.

Click to show full story

Survey finds many Americans do not consider key safety factors when choosing OTC pain relievers

OTC pain reliever considerations

A recent survey1 conducted by the US Pain Foundation, with support from Johnson & Johnson Consumer Inc., found that 97% of Americans feel confident when choosing which type of over-the-counter (OTC) pain medicines to take. However, the survey also revealed that many consumers disregard critical safety factors—such as their age, health conditions, and other medicines they are currently taking—when choosing an OTC pain reliever.

Click to show full story

Reference: 1. In July 2016, the U.S.Pain Foundation, with support from Johnson & Johnson Consumer Inc., conducted a survey on American consumers' perceptions and behaviors when it comes to the appropriate selection and use of OTC pain relievers. The survey was conducted from June 24-July 5, 2016 among nearly 1,300 U.S. adults who have used an OTC pain reliever in the last 90 days. The survey included an oversampling of respondents with high blood pressure (n=125) and respondents who have cardiovascular disease (n=125).